An Alberta expansion pushed up the price of a Canadian marijuana stock Friday. Here’s some small stocks making big moves on Friday, November 17, 2017 (as of 4 pm EST):
National Access Cannabis Corp. (TSXV:NAC), a Canadian marijuana stock, jumped 17% to $0.27 on Friday after announcing that it has expanded its Alberta operations with the signing of a lease for a new care clinic in Edmonton’s Old Strathcona District.
As well, shares of Oncolytics Biotech Inc. (TSX:ONC) surged 35% to $0.77 as the biotech company said it has entered into a Regional Licensing Agreement with Adlai Nortye (Adlai), which will have exclusive development and commercialization rights to REOLYSIN in China, Hong Kong, Macau, Singapore, South Korea and Taiwan. Oncolytics will receive an upfront licensing fee and milestone payments of US$21.2 million, and is eligible to receive up to an additional US$65.4 million upon achievement of clinical, regulatory and commercialization milestones.
Tornado Global Hydrovacs Ltd. (TSXV:TGH), meanwhile, reported that its third-quarter revenue increased 13% to $7.6 million, while swinging to a profit of $79,000 during the quarter. Tornado Global Hydrovacs stock moved up 28% to $0.115 following the announcement.
Finally, Macarthur Minerals Limited (TSXV:MMS) shares gained 21% to $0.085 after the junior explorer announced that it has finalized heritage agreements with the Palyku and Njamal native title claimants, paying the way for all the Exploration Licences in the Pilbara to be granted in a matter of days.
Disclosure: Neither the author nor any of the principals at SmallCapPower, or their family members, own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below:
The Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks associated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict.